JP2023540171A5 - - Google Patents
Info
- Publication number
- JP2023540171A5 JP2023540171A5 JP2023506220A JP2023506220A JP2023540171A5 JP 2023540171 A5 JP2023540171 A5 JP 2023540171A5 JP 2023506220 A JP2023506220 A JP 2023506220A JP 2023506220 A JP2023506220 A JP 2023506220A JP 2023540171 A5 JP2023540171 A5 JP 2023540171A5
- Authority
- JP
- Japan
- Prior art keywords
- solution composition
- pharmaceutical solution
- composition according
- ics
- laba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382710.0 | 2020-07-31 | ||
| EP20382710 | 2020-07-31 | ||
| PCT/EP2021/071369 WO2022023515A1 (en) | 2020-07-31 | 2021-07-30 | Combination therapy for inhalation administration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540171A JP2023540171A (ja) | 2023-09-22 |
| JP2023540171A5 true JP2023540171A5 (https=) | 2025-11-27 |
| JP7828949B2 JP7828949B2 (ja) | 2026-03-12 |
Family
ID=72039503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023506220A Active JP7828949B2 (ja) | 2020-07-31 | 2021-07-30 | 吸入投与のための併用療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230270754A1 (https=) |
| EP (1) | EP4188327B1 (https=) |
| JP (1) | JP7828949B2 (https=) |
| KR (1) | KR20230052903A (https=) |
| CN (1) | CN115989032A (https=) |
| AU (1) | AU2021314977B2 (https=) |
| BR (1) | BR112023001689A2 (https=) |
| CA (1) | CA3186956A1 (https=) |
| ES (1) | ES3037198T3 (https=) |
| FI (1) | FI4188327T3 (https=) |
| MX (1) | MX2023001201A (https=) |
| PL (1) | PL4188327T3 (https=) |
| WO (1) | WO2022023515A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230270754A1 (en) | 2020-07-31 | 2023-08-31 | Chemo Research, S.L. | Combination therapy for inhalation administration |
| WO2026057872A1 (en) * | 2024-09-16 | 2026-03-19 | Invox Belgium Nv | Inhalable compositions |
| CN121714579A (zh) * | 2026-02-25 | 2026-03-24 | 上海臣邦医药科技股份有限公司 | 一种三联复方吸入制剂的药物组合物及其制备方法和应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851317A (en) | 1987-11-04 | 1989-07-25 | E. I. Du Pont De Nemours And Company | Laminar flow toning station having conductive and nonconductive elements therein |
| UA62917C2 (en) * | 1995-06-27 | 2004-01-15 | Berinher Inhelheim Kg | Medicinal composition for generating propellant-free aerosols |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| DE19653969A1 (de) | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| DE59901669D1 (de) * | 1998-10-17 | 2002-07-11 | Boehringer Ingelheim Pharma | Lagerfähiges wirkstoffkonzentrat mit formoterol |
| AU2000250701B2 (en) | 2000-05-22 | 2004-07-01 | Chiesi Farmaceutici S.P.A. | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| FI20002216A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
| FI20002215A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
| US20020137764A1 (en) * | 2000-10-31 | 2002-09-26 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
| CA2436540C (en) | 2000-10-31 | 2008-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and corticosteroids |
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| JP2008538758A (ja) | 2005-04-23 | 2008-11-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物 |
| ITMI20051999A1 (it) * | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
| US20070293460A1 (en) | 2005-10-31 | 2007-12-20 | Richie's Pharmacy And Medical Supply, Incorporated | Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
| US20070098644A1 (en) | 2005-10-31 | 2007-05-03 | Richie's Pharmacy And Medical Supply, Incorporated | Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
| DE102006023756A1 (de) | 2006-05-20 | 2007-11-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ethanolhaltige Aerosolformulierung für die Inhalation |
| UY30542A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de agonistas beta |
| EP2515855B3 (en) | 2009-12-23 | 2023-05-03 | Chiesi Farmaceutici S.p.A. | Combination therapy for COPD |
| SG181870A1 (en) | 2009-12-23 | 2012-07-30 | Chiesi Farma Spa | Aerosol formulation for copd |
| BR112012015334A2 (pt) | 2009-12-23 | 2016-03-15 | Chiesi Farma Spa | terapia combinada para doença pulmonar obstrutiva crônica |
| US20120220557A1 (en) | 2011-02-17 | 2012-08-30 | Chiesi Farmaceutici S.P.A. | Liquid propellant-free formulation comprising an antimuscarinic drug |
| BR112015010842B1 (pt) | 2012-12-21 | 2021-03-30 | Boehringer Ingelheim Vetmedica Gmbh | Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos |
| RS57687B1 (sr) | 2013-12-30 | 2018-11-30 | Chiesi Farm Spa | Pod pritiskom stabilan aerosolni rastvor kompozicije glikopironijum bromida i kombinacije formoterola |
| GEAP201814192A (en) | 2013-12-30 | 2018-02-26 | Chiesi Farm Spa | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
| US9554992B2 (en) | 2014-06-09 | 2017-01-31 | Chiesi Farmaceutici S.P.A. | Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic |
| ES2759247T3 (es) | 2014-06-18 | 2020-05-08 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos |
| GB201520862D0 (en) * | 2015-11-25 | 2016-01-13 | Jagotec Ag | Pharmaceutical composition |
| US10098837B2 (en) | 2016-07-28 | 2018-10-16 | Chiesi Farmaceutici S.P.A. | Combination therapy for COPD |
| WO2020167893A1 (en) | 2019-02-13 | 2020-08-20 | Molecular Infusions, Llc | Methods for non-irritating pulmonary administration of cannabinoids using soft mist inhalers |
| US20230270754A1 (en) | 2020-07-31 | 2023-08-31 | Chemo Research, S.L. | Combination therapy for inhalation administration |
-
2021
- 2021-07-30 US US18/007,426 patent/US20230270754A1/en active Pending
- 2021-07-30 CA CA3186956A patent/CA3186956A1/en active Pending
- 2021-07-30 AU AU2021314977A patent/AU2021314977B2/en active Active
- 2021-07-30 EP EP21755917.8A patent/EP4188327B1/en active Active
- 2021-07-30 KR KR1020237006563A patent/KR20230052903A/ko active Pending
- 2021-07-30 WO PCT/EP2021/071369 patent/WO2022023515A1/en not_active Ceased
- 2021-07-30 JP JP2023506220A patent/JP7828949B2/ja active Active
- 2021-07-30 PL PL21755917.8T patent/PL4188327T3/pl unknown
- 2021-07-30 CN CN202180051794.2A patent/CN115989032A/zh active Pending
- 2021-07-30 MX MX2023001201A patent/MX2023001201A/es unknown
- 2021-07-30 FI FIEP21755917.8T patent/FI4188327T3/fi active
- 2021-07-30 BR BR112023001689A patent/BR112023001689A2/pt unknown
- 2021-07-30 ES ES21755917T patent/ES3037198T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540171A5 (https=) | ||
| US20170027908A1 (en) | Pharmaceutical Composition | |
| AU2011315315B2 (en) | Pharmaceutical composition | |
| HRP20140864T1 (hr) | Kombinacije koje sadrže antimuskarinska sredstva i beta-adrenergiäśke agoniste | |
| WO2014016548A2 (en) | Pharmaceutical composition | |
| EP1531866A1 (en) | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids | |
| JP2024525567A5 (https=) | ||
| JP2013542940A5 (https=) | ||
| NZ600789A (en) | Aerosol formulation for copd | |
| JP2016503390A (ja) | 医薬組成物 | |
| JP2019528316A5 (https=) | ||
| FI4188327T3 (fi) | Yhdistelmähoito inhalaatioannosteluun | |
| CN106470700A (zh) | 用于治疗copd的噻托溴铵、福莫特罗和布地奈德的组合 | |
| JP2025527924A (ja) | 呼吸器系疾患を予防または治療するための吸入用薬物組成物 | |
| CN104955448A (zh) | 适用于吸入治疗的包含多组分结晶颗粒的药物组合物 | |
| EP3400214B1 (en) | Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives | |
| AU2015275933A1 (en) | Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent | |
| HRP20140818T1 (hr) | Farmaceutske aerosolne formulacije formoterola i beklometazon-dipropionata | |
| JP2024546201A (ja) | サルブタモールを含む医薬組成物 | |
| TWI922835B (zh) | 預防或治療呼吸系統疾病的吸入用藥物組合物 | |
| JP2025517809A5 (https=) | ||
| NZ707754B2 (en) | Combination of glycopyrrolate and a beta2 -agonist | |
| HK40000409B (en) | Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives | |
| HK40000409A (en) | Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives |